# Immunovant, Inc. (IMVT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IMVT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -475.30M | $ -433.21M | $ 0 | $ 986.14M |
| 2024 | $ 0 | $ -402.26M | $ -342.28M | $ 23.0K | $ 352.62M |
| 2023 | $ 0 | $ -263.23M | $ -227.67M | $ 306.0K | $ 679.34M |
| 2022 | $ 0 | $ -221.97M | $ -185.04M | $ 1.51M | $ 414.68M |
| 2021 | $ 0 | $ -163.70M | $ -113.97M | $ 2.76M | $ 505.15M |
| 2020 | $ 0 | $ -127.17M | $ -107.02M | $ 3.50M | $ 414.15M |
| 2019 | $ 0 | $ -14.18M | $ -692.7K | $ 2.90M | $ 111.86M |
| 2018 | $ 0 | $ -25.84M | $ -21.1K | $ 0 | $ -1.50M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.07 |
| Current Ratio | 15.74 |

## Other views

- [Metrics](https://sponda.capital/en/IMVT.md)
- [Charts](https://sponda.capital/en/IMVT/charts.md)
- [Compare](https://sponda.capital/en/IMVT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.